Nanoviricides Inc (NNVC)
1.85
+0.02
(+1.09%)
USD |
NYAM |
May 10, 16:00
1.87
+0.02
(+1.08%)
After-Hours: 18:52
Nanoviricides Price to Book Value: 1.750 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 1.731 |
| May 08, 2024 | 1.920 |
| May 07, 2024 | 1.589 |
| May 06, 2024 | 1.324 |
| May 03, 2024 | 1.069 |
| May 02, 2024 | 1.135 |
| May 01, 2024 | 1.069 |
| April 30, 2024 | 1.135 |
| April 29, 2024 | 1.069 |
| April 26, 2024 | 1.041 |
| April 25, 2024 | 1.050 |
| April 24, 2024 | 1.088 |
| April 23, 2024 | 1.078 |
| April 22, 2024 | 1.060 |
| April 19, 2024 | 1.041 |
| April 18, 2024 | 1.112 |
| April 17, 2024 | 1.097 |
| April 16, 2024 | 1.116 |
| April 15, 2024 | 1.088 |
| April 12, 2024 | 1.182 |
| April 11, 2024 | 1.201 |
| April 10, 2024 | 1.239 |
| April 09, 2024 | 1.287 |
| April 08, 2024 | 1.315 |
| April 05, 2024 | 1.296 |
| Date | Value |
|---|---|
| April 04, 2024 | 1.296 |
| April 03, 2024 | 1.211 |
| April 02, 2024 | 1.201 |
| April 01, 2024 | 1.230 |
| March 28, 2024 | 1.097 |
| March 27, 2024 | 1.069 |
| March 26, 2024 | 1.078 |
| March 25, 2024 | 1.069 |
| March 22, 2024 | 1.078 |
| March 21, 2024 | 1.078 |
| March 20, 2024 | 1.088 |
| March 19, 2024 | 1.088 |
| March 18, 2024 | 1.088 |
| March 15, 2024 | 1.135 |
| March 14, 2024 | 1.107 |
| March 13, 2024 | 1.069 |
| March 12, 2024 | 1.069 |
| March 11, 2024 | 1.060 |
| March 08, 2024 | 1.050 |
| March 07, 2024 | 1.069 |
| March 06, 2024 | 1.097 |
| March 05, 2024 | 1.145 |
| March 04, 2024 | 1.145 |
| March 01, 2024 | 1.192 |
| February 29, 2024 | 1.277 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5227
Minimum
May 12 2022
16.11
Maximum
Jan 31 2020
1.668
Average
1.232
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.774 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7084 |
| Theriva Biologics Inc | 0.1624 |
| Oragenics Inc | 5.233 |
Price to Book Value Related Metrics
| Price | 1.85 |
| Earnings Yield | -43.78% |
| Market Cap | 21.79M |